CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
8.46 / 10
Outperform
Analyst consensus is bullish: two Strong Buy ratings, one with 100% historic win rate. Fund‑flow score is 7.5 (good) with overall inflow ratio 0.39 but negative trend; medium‑size trades are positive while other size categories remain negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate100.0%
Is money flowing into or out of CGON?
- CGON holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.46/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
